Differential regulation of peroxisome proliferator activated receptor γ1 (PPARγ1) and PPARγ2 messenger RNA expression in the early stages of adipogenesis

Cell Growth and Differentiation

Volumn 10, Issue 1, 1999, Pages 43-48

  Saladin, Régis ^a   Fajas, Lluis ^b   Dana, Sharon ^a   Halvorsen, Yuan Di ^c   Auwerx, Johan ^b   Briggs, Michael ^a,d  

^a LIGAND PHARMACEUTICALS INC   (United States)

^b INSTITUT PASTEUR DE LILLE   (France)

^c Zen Bio Inc   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HELIX LOOP HELIX PROTEIN; ISOBUTYLMETHYLXANTHINE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

3T3 CELLS; ADIPOCYTES; ANIMALS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICE; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0032979514     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Martin, L. F., Hunter, S. M., Lauve, R. M., and O'Leary, J. P. Severe obesity: expensive to society, frustrating to treat, but important to confront. Southern Med. J., 88: 895-902, 1995.
2. Hirsch, J. Adipose cellularity in relation to human adiposity. In: G. H. Stollerman (ed.), Advances in Internal Medicine, Vol. 17, pp. 289-300. Chicago: Year Book Medical Publishers, 1971.
3. Cornelius, P., MacDouglad, O. A., and Lane, M. D. Regulation of adipocyte development. Annu. Rev. Nutr., 14: 99-129, 1994.
4. Prins, J. B., and O'Rahilly, S. Regulation of adipose cell number in man. Clin. Sci., 92: 3-11, 1997.
5. Reed, B. C., and Lane, M. D. Expression of insulin receptors during preadipocyte differentiation. Adv. Enzyme. Regul., 18: 97-117, 1980.
6. Deslex, S., Negrel, R., Vannier, C., Etienne, J., and Ailhaud, G. Differentiation of human adipocyte precursors in a chemically defined serum-free medium. Int. J. Obesity, 11: 19-27, 1986.
7. Fajas, L., Fruchart, J. C., and Auwerx, J. Transcriptional control of adipogenesis. Curr. Opin. Cell Biol., in press, 1999.
8. Mandrup, S., and Lane, M. D. Regulating adipogenesis. J. Biol. Chem., 272: 5367-5370, 1997.
9. MacDouglad, O. A., and Lane, M. D. Adipocyte differentiation. When precursors are also regulators. Curr. Biol., 5: 618-621, 1995.
10. Yeh, W. C., Cao, Z., Classon, M., and McKnight, L. M. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev., 9: 168-181, 1995.
11. Freytag, S. O., Paielli, D. L., and Gilbert, J. D. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev., 8: 1654-1663, 1994.
12. Shao, D., and Lazar, M. A. Peroxisome proliferator activated receptor γ, CCAAT/enhancer-binding protein α, and cell cycle status regulate the commitment to adipocyte differentiation. J. Biol. Chem., 272: 21473-21478, 1997.
13. Kim, J., and Spiegelman, B. M. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev., 10: 1096-1107, 1996.
14. Brun, R. P., Tontonoz, P., Forman, B. M., Ellis, R., Chen, J., Evans, R. M., and Spiegelman, B. M. Differential activation of adipogenesis by multiple PPAR isoforms. Genes Dev., 10: 974-984, 1996.
15. Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., and Spiegelman, B. M. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev., 8: 1224-1234, 1994.
16. Tontonoz, P., Hu, E., and Spiegelman, B. M. Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ. Cell, 79: 1147-1156, 1994.
17. Zhu, Y., Alvares, K., Huang, Q., Rao, M. S., and Reddy, J. K. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J. Biol. Chem., 268: 26817-26820, 1993.
18. Mukherjee, R., Jow, L., Croston, G. E., and Paterniti, J. R., Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1, and activation with retinoid X receptor agonists, and antagonists. J. Biol. Chem., 272: 8071-8076, 1997.
19. Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., Najib, J., Laville, M., Fruchart, J. C., Deeb, S., Vidal-Puig, A., Flier, J., Briggs, M. R., Staels, B., Vidal, H., and Auwerx, J. The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem., 272: 18779-18789, 1997.
20. Vidal-Puig, A. J., Considine, R. V., Jimenez-Linan, M., Werman, A., Pories, W. J., Caro, J. F., and Flier, J. S. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J. Clin. Invest., 99: 2416-2422, 1997.
21. Werman, A., Hollenberg, A., Solanes, G., Bjørbaek, C., Vidal-Puig, A. J., and Flier, J. S. Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem., 272: 20230-20235, 1997.
22. Altiok, S., Xu, M., and Spiegelman, B. M. PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev., 11: 1987-1998, 1997.
23. Schoonjans, K., Staels, B., and Auwerx, J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res., 37: 907-925, 1996.
24. Chawla, A., and Lazar, M. A. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc. Natl. Acad. Sci. USA, 91: 1786-1790, 1994.
25. Xue, J. C., Schwarz, E. J., Chawla, A., and Lazar, M. A. Distinct stages in adipogenesis revealed by retinoid inhibition of differentiation after induction of PPARγ. Mol. Cell. Biol., 16: 1567-1575, 1996.
26. DiRenzo, J., Sàderstràm, M., Kurokawa, R., Ogliastro, M. H., Ricote, M., Ingrey, S., Hörlein, A., Rosenfeld, M. G., and Glass, C. K. Peroxisome proliferator-activated receptor and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators and corepressors. Mol. Cell. Biol., 17: 2166-2176, 1997.
27. Tae, H. J., Zhang, S., and Kim, K. H. cAMP activation of CAAT enhancer-binding protein-β gene expression and promoter I of acetyl-CoA carboxylase. J. Biol. Chem., 270: 21487-21494, 1995.
28. Cao, Z., Umek, R., and McKnight, S. L. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev., 5: 1538-1542, 1991.
29. Wu, Z., Xie, Y., Bucher, N. L. R., and Farmer, S. R. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev., 9: 2350-2363, 1995.
30. Clarke, S. L., Robinson, C. E., and Gimble, J. M. CAAT/enhancer binding proteins directly modulate transcription from the peraxisome proliferator-activated receptor γ2 promoter. Biochem. Biophys. Res. Commun., 240: 99-103, 1997.
31. Kim, J. B., Wright, H. M., Wright, M., and Spiegelman, B. M. AAD1/SREBP-1 activates PPARγ through the production of endogenous ligand. Proc. Natl. Acad. Sci. USA, 95: 4333-4337, 1998.
32. Petruschke, T. H., and Hauner, H. Tumor necrosis factor-α prevents the differentiation of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J. Clin. Endocrinol. Metab., 76: 742-747, 1993.
33. Saladin, R., De Vos, P., Guerre-Millo, M., Leturque, A., Girard, J., Staels, B., and Auwerx, J. Transient increase in obese gene expression after food intake or insulin administration. Nature (Lond.), 377: 527-529, 1995.
34. Laville, M., Auboeuf, D., Khalfallah, Y., Vega, N., Riou, J. P., and Vidal, H. Acute regulation by insulin of phosphatidylinositol-3-kinase, Rad, Glut 4, and lipoprotein lipase mRNA levels in human muscle. J. Clin. Invest., 98: 43-49, 1996.
35. Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., and Vidal, H. Tissue distribution and quantification of the expression of PPARs and LXRa in humans: no alterations in adipose tissue of obese and NIDDM patients. Diabetes, 46: 1319-1327, 1997.
36. McDonnell, D. P., Vegeto, E., and Gleeson M. A. G. Nuclear hormone receptors as targets for new drug discovery. Bio/Technology, 11: 1256-1261, 1993.